{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:44Z","timestamp":1786991324157,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:00:00Z","timestamp":1794700800000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23EY028230"],"award-info":[{"award-number":["K23EY028230"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HG010863"],"award-info":[{"award-number":["R01HG010863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50GM115305"],"award-info":[{"award-number":["P50GM115305"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI152183"],"award-info":[{"award-number":["R01AI152183"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006065","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","award":["GNT2028952"],"award-info":[{"award-number":["GNT2028952"]}],"id":[{"id":"10.13039\/501100006065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006065","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","award":["WANMA\/EL2022\/4"],"award-info":[{"award-number":["WANMA\/EL2022\/4"]}],"id":[{"id":"10.13039\/501100006065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT11234999"],"award-info":[{"award-number":["GNT11234999"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["U01AI154659"],"award-info":[{"award-number":["U01AI154659"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["K43 TW011178-01"],"award-info":[{"award-number":["K43 TW011178-01"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["R21AI139021"],"award-info":[{"award-number":["R21AI139021"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["EY001792"],"award-info":[{"award-number":["EY001792"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["K08AI185260"],"award-info":[{"award-number":["K08AI185260"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["2 D43 TW010559"],"award-info":[{"award-number":["2 D43 TW010559"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007475","name":"Canadian Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003980","name":"National Eczema Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024253","name":"Western Australian Future Health and Innovation Fund, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020261","name":"Eczema Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jaip.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:53:05Z","timestamp":1754668385000},"page":"3042-3053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions"],"prefix":"10.1016","volume":"13","author":[{"given":"Yueran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajirah N.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Ostrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Mallal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni P.","family":"Dodiuk-Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Martin-Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Gangula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelby","family":"Mahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Rashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna S.","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ali","family":"Tahboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pedretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuti","family":"Choshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tafadzwa","family":"Chimbetete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rannakoe","family":"Lehloenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonny G.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(14)71011-4","article-title":"The expanding role of co-trimoxazole in developing countries","volume":"15","author":"Church","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaip.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.jaip.2021.05.008","article-title":"Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System","volume":"9","author":"Bluestein","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.08.001_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1259611","article-title":"Severe cutaneous adverse reactions to drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jamadermatol.2022.4519","article-title":"Drug reaction with eosinophilia and systemic symptoms","volume":"159","author":"Krantz","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-024-00514-0","article-title":"Severe cutaneous adverse reactions","volume":"10","author":"Hung","year":"2024","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jaip.2025.08.001_bib6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamadermatol.2024.0210","article-title":"Human leukocyte antigens and sulfamethoxazole\/cotrimoxazole-induced severe cutaneous adverse reactions: a systematic review and meta-analysis","volume":"160","author":"Wu","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2018.5360","article-title":"Evaluation of prospective HLA-B\u221713:01 screening to prevent dapsone hypersensitivity syndrome in patients with leprosy","volume":"155","author":"Liu","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jaip.2022.04.027","article-title":"Practical implementation of genetics: new concepts in immunogenomics to predict, prevent, and diagnose drug hypersensitivity","volume":"10","author":"Deshpande","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.08.001_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.994277","article-title":"Spatial disparities of HIV prevalence in South Africa. Do sociodemographic, behavioral, and biological factors explain this spatial variability?","volume":"10","author":"Ugwu","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jaip.2025.08.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100936","article-title":"The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) \u2013 providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions","volume":"17","author":"James","year":"2024","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2025.08.001_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: comparison with case\u2013control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2025.08.001_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized medicine","volume":"84","author":"Roden","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2025.08.001_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.humimm.2018.01.004","article-title":"Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 159 individuals from the Worcester region of the Western Cape province of South Africa","volume":"79","author":"Grifoni","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.humimm.2017.04.006","article-title":"Human leukocyte antigen class I (A, B and C) allele and haplotype variation in a South African Mixed ancestry population","volume":"78","author":"Loubser","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.humimm.2019.12.003","article-title":"Human leukocyte antigen class I (A, B, C) and class II (DPB1, DQB1, DRB1) allele and haplotype variation in Black South African individuals","volume":"81","author":"Loubser","year":"2020","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008177","article-title":"Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV","volume":"15","author":"Currenti","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaip.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00251-013-0714-9","article-title":"MHCcluster, a method for functional clustering of MHC molecules","volume":"65","author":"Thomsen","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaip.2025.08.001_bib21","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.4049\/jimmunol.172.7.4314","article-title":"Identifying human MHC supertypes using bioinformatic methods","volume":"172","author":"Doytchinova","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib23","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.4049\/jimmunol.171.11.5964","article-title":"Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype","volume":"171","author":"Sidney","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib24","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaip.2025.08.001_bib25","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jaip.2025.08.001_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-0716-3441-7_6","article-title":"Protein-ligand blind docking using CB-Dock2","volume":"2714","author":"Liu","year":"2024","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaip.2025.08.001_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2025.08.001_bib29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/cpt.1915","article-title":"Genetic association of co-trimoxazole-induced severe cutaneous adverse reactions is phenotype-specific: HLA class I genotypes and haplotypes","volume":"108","author":"Sukasem","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2025.08.001_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/FPC.0000000000000153","article-title":"Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions","volume":"25","author":"Kongpan","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2025.08.001_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12929-022-00845-8","article-title":"Functional and structural characteristics of HLA-B\u221713:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity","volume":"29","author":"Jiang","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jaip.2025.08.001_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658593","article-title":"Characterization of T-cell responses to SMX and SMX-NO in co-trimoxazole hypersensitivity patients expressing HLA-B\u221713:01","volume":"12","author":"Pratoomwun","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jaci.2016.11.032","article-title":"Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells","volume":"140","author":"Gibson","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.08.001_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.103.050112","article-title":"Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans","volume":"306","author":"Farrell","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaip.2025.08.001_bib35","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/all.13769","article-title":"Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B\u221713:01","volume":"74","author":"Zhao","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.08.001_bib36","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/jid.2013.192","article-title":"Association between HLA-B\u22171301 and dapsone-induced hypersensitivity reactions among leprosy patients in China","volume":"133","author":"Wang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib37","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/jac\/dku315","article-title":"CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations","volume":"69","author":"Carr","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2025.08.001_bib38","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/cid\/cit021","article-title":"Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population","volume":"56","author":"Carr","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2025.08.001_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/j.1875-9114.1998.tb03904.x","article-title":"Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone","volume":"18","author":"Holtzer","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaip.2025.08.001_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr4238","article-title":"HIV-1 adapts to HLA class II-associated selection pressure exerted by CD4+ and CD8+ T cells","volume":"11","author":"Alves","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaip.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jid.2019.12.025","article-title":"Association of HLA-A\u221711:01 with sulfonamide-related severe cutaneous adverse reactions in Japanese patients","volume":"140","author":"Nakamura","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib42","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib43","first-page":"914","article-title":"Familial occurrence of Stevens-Johnson syndrome","volume":"137","author":"Fischer","year":"1983","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaip.2025.08.001_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaip.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.08.001_bib46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2217\/pgs.14.69","article-title":"HLA-B\u221713:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population","volume":"15","author":"Yang","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2025.08.001_bib47","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jaip.2024.02.041","article-title":"Association of HLA-A\u221711:01, HLA-B\u221739:01, and HLA-B\u221756:03 with salazosulfapyridine-induced cutaneous adverse drug reactions","volume":"12","author":"Fukunaga","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.08.001_bib48","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1038\/s41467-024-52990-3","article-title":"Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"15","author":"Gibson","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2025.08.001_bib49","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1038\/srep05981","article-title":"Trans-ethnic study confirmed independent associations of HLA-A\u221702:06 and HLA-B\u221744:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications","volume":"4","author":"Ueta","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1038\/srep04862","article-title":"Independent strong association of HLA-A\u221702:06 and HLA-B\u221744:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement","volume":"4","author":"Ueta","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.08.001_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3349\/ymj.2016.57.1.118","article-title":"HLA allele frequencies in 5802 Koreans: varied allele types associated with SJS\/TEN according to culprit drugs","volume":"57","author":"Park","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaip.2025.08.001_bib52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphar.2017.00879","article-title":"Association of HLA-A and HLA-B alleles with lamotrigine-induced cutaneous adverse drug reactions in the Thai population","volume":"8","author":"Koomdee","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2025.08.001_bib53","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1038\/s41598-017-08876-0","article-title":"Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles","volume":"7","author":"Pavlos","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.08.001_bib54","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1016\/j.jaip.2019.07.013","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis associated with carbonic anhydrase inhibitors: epidemiology, genetics, and insights into mechanisms","volume":"7","author":"Trubiano","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jaip.2019.05.010","article-title":"Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis leads to extensive cutaneous involvement","volume":"7","author":"Kim","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.08.001_bib56","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1016\/S2352-3018(23)00142-X","article-title":"Is the USA on track to end the HIV epidemic?","volume":"10","author":"Guilamo-Ramos","year":"2023","journal-title":"Lancet HIV"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825007627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825007627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:05:48Z","timestamp":1774958748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825007627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213219825007627"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.08.001","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}